Intracellular Angiopoietin-1 Promotes TKI-Resistance via Activation of JAK/STAT5 Pathway in Chronic Myeloid Leukemia

The authors investigated the role of angiopoietin-1 as a potential prognostic factor for drug resistance in chronic myeloid leukemia.